Zobrazeno 1 - 10
of 2 948
pro vyhledávání: '"Mucosal healing"'
Autor:
Daniel C. Baumgart, Andreas Stallmach, Philip Grunert, Stefan Schubert, Stefanie Howaldt, Ulrike von Arnim, Thomas Ochsenkühn, Jürgen Stein, Andreas Lügering, Daniel Schmidt, Marten Schulz, Andreas Fischer
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract The impact of ustekinumab (UST) on mucosal- and fistula healing and extraintestinal manifestations (EIM) in Crohn’s disease (CD) were not fully elucidated in the registration trials. In this prospective, multicenter study (EudraCT number:
Externí odkaz:
https://doaj.org/article/8e26c76e4f934deda619918c95c952be
Autor:
Ji Eun Kim, Minjee Kim, Min-Ji Kim, Eun Ran Kim, Sung Noh Hong, Dong Kyung Chang, Sang Yun Ha, Young-Ho Kim
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract Limited research has been performed to determine if histologic improvement serves as a prognosticator for endoscopic remission, a key therapeutic target for ulcerative colitis (UC). The primary aim of the study was to evaluate if histologica
Externí odkaz:
https://doaj.org/article/07c59cee6d3e44729125d6e3d42d3b48
Publikováno v:
Drug Design, Development and Therapy, Vol Volume 18, Pp 2793-2812 (2024)
Siqi Zhu,1– 3,* Yajun Cui,2,3,* Weidong Zhang,2,3 Yu Ji,2,3 Lingshuang Li,2,3 Shenglei Luo,4 Jing Cui,5,6 Minqi Li2,3 1School of Stomatology, Jinzhou Medical University, Jinzhou, People’s Republic of China; 2Department of Bone Metabolism,
Externí odkaz:
https://doaj.org/article/ac62ce47666b44848961f2015dcce6d5
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
Ulcerative colitis (UC), characterized by its recurrent nature, imposes a significant disease burden and compromises the quality of life. Emerging evidence suggests that achieving clinical remission is not sufficient for long-term remission. In pursu
Externí odkaz:
https://doaj.org/article/010d9adf48834fb68621b8a8f61e4e2e
Publikováno v:
Modern Medicine, Vol 31, Iss 1, Pp 13-20 (2024)
Background: Due to the rapid development of new diagnostic and therapeutic endoscopic techniques, there has been a gap between their development and implementation in daily practice, as well as in their uptake in guideline recommendations1. We invest
Externí odkaz:
https://doaj.org/article/07acb87e9cf54857a06ab0b314bd17ba
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 25, Iss 1 (2024)
OBJECTIVE: To evaluate the costs and benefits associated with the use of biologics and Janus kinase inhibitors (JAKi) for the treatment of bio-experienced patients suffering from ulcerative colitis in Italy. METHODS: This pharmacoeconomic analysis c
Externí odkaz:
https://doaj.org/article/3c3ee42f6305451c9dab26f5ae31d35f
Publikováno v:
Journal of Inflammation Research, Vol Volume 16, Pp 2549-2559 (2023)
Xijing Huang,1,* Yan Pan,1,* Ya Liu,1,* Zhou Zhou,1 Yinghui Zhang,1 Caiping Gao,1 Chong He1,2 1Department of Gastroenterology, Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China, Chengdu, Peop
Externí odkaz:
https://doaj.org/article/cb73d2e209c5477cb3022d2bb1a10291
Publikováno v:
BMC Gastroenterology, Vol 23, Iss 1, Pp 1-7 (2023)
Abstract Background Psychological stress has been proved to be a risk factor for exacerbation for ulcerative colitis (UC). However, traditional approaches of quantifying psychological stress using psychological scales are time-consuming and the resul
Externí odkaz:
https://doaj.org/article/74a6e25425c145a0bbaa4dbdb8eee143
Publikováno v:
International Journal of Nanomedicine, Vol Volume 18, Pp 2799-2818 (2023)
Xiaonan Liang,1,* Chenyang Li,1,* Jia Song,1 Airu Liu,1 Chen Wang,1 Wenxin Wang,1 Yaxing Kang,1,2 Donglei Sun,1 Jiaming Qian,1,3 Xiaolan Zhang1 1Department of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Key Labora
Externí odkaz:
https://doaj.org/article/0c942633521646ed90c7e479737e0c92
Autor:
Philippe Pinton
Publikováno v:
Annals of Medicine, Vol 55, Iss 2 (2023)
AbstractIntroduction Artificial intelligence (AI) is expected to impact all facets of inflammatory bowel disease (IBD) management, including disease assessment, treatment decisions, discovery and development of new biomarkers and therapeutics, as wel
Externí odkaz:
https://doaj.org/article/5c5c1ff11d2a422b825d2ca7d0b287c4